Stephens & Co. Maintains Overweight on Certara, Lowers Price Target to $9

Benzinga Newsdesk www.benzinga.com Negative 87.5%

Neg 87.5% Neu 0% Pos 0%

Stephens & Co. analyst Jeff Garro maintains Certara (NASDAQ:CERT) with a Overweight and lowers the price target from $10 to $9.